Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Travel Medicine | 5 | 2014 | 83 | 0.750 |
Why?
|
| Travel | 8 | 2016 | 806 | 0.610 |
Why?
|
| Tropical Medicine | 1 | 2014 | 52 | 0.440 |
Why?
|
| Communicable Diseases | 2 | 2014 | 873 | 0.310 |
Why?
|
| Dengue Virus | 3 | 2016 | 202 | 0.300 |
Why?
|
| Physicians, Primary Care | 1 | 2014 | 622 | 0.280 |
Why?
|
| Dengue | 3 | 2016 | 257 | 0.280 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2015 | 4055 | 0.240 |
Why?
|
| Referral and Consultation | 1 | 2014 | 3615 | 0.180 |
Why?
|
| Serologic Tests | 2 | 2013 | 382 | 0.180 |
Why?
|
| Microcirculation | 1 | 2023 | 1282 | 0.150 |
Why?
|
| Hepatitis B | 2 | 2013 | 709 | 0.140 |
Why?
|
| Scabies | 1 | 2015 | 14 | 0.130 |
Why?
|
| Diagnostic Errors | 2 | 2013 | 1276 | 0.120 |
Why?
|
| Endemic Diseases | 2 | 2013 | 190 | 0.120 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2020 | 668 | 0.110 |
Why?
|
| HIV Infections | 5 | 2023 | 17531 | 0.110 |
Why?
|
| Dengue Vaccines | 1 | 2013 | 16 | 0.110 |
Why?
|
| Medication Adherence | 2 | 2015 | 2190 | 0.100 |
Why?
|
| Genes, MHC Class I | 1 | 2010 | 236 | 0.080 |
Why?
|
| Comprehension | 1 | 2015 | 636 | 0.080 |
Why?
|
| Vaccination | 4 | 2016 | 3430 | 0.080 |
Why?
|
| Health Literacy | 1 | 2015 | 465 | 0.080 |
Why?
|
| HLA-B Antigens | 1 | 2010 | 329 | 0.080 |
Why?
|
| Minocycline | 1 | 2009 | 168 | 0.070 |
Why?
|
| Mass Screening | 2 | 2013 | 5449 | 0.070 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2015 | 1899 | 0.070 |
Why?
|
| Antibodies, Viral | 2 | 2016 | 3213 | 0.060 |
Why?
|
| Counseling | 1 | 2013 | 1551 | 0.060 |
Why?
|
| Immunoglobulin G | 2 | 2016 | 4555 | 0.060 |
Why?
|
| Antigen Presentation | 1 | 2010 | 1250 | 0.060 |
Why?
|
| Yellow Fever Vaccine | 2 | 2016 | 38 | 0.060 |
Why?
|
| Disease Outbreaks | 1 | 2013 | 1761 | 0.060 |
Why?
|
| Boston | 5 | 2020 | 9334 | 0.050 |
Why?
|
| Dideoxynucleosides | 1 | 2023 | 135 | 0.050 |
Why?
|
| Self Report | 1 | 2014 | 3768 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2013 | 2693 | 0.050 |
Why?
|
| Pancreatitis | 1 | 2009 | 1086 | 0.050 |
Why?
|
| Lamivudine | 1 | 2023 | 368 | 0.050 |
Why?
|
| Skin | 1 | 2015 | 4481 | 0.050 |
Why?
|
| Oxazines | 1 | 2023 | 358 | 0.050 |
Why?
|
| Decision Making | 1 | 2015 | 3955 | 0.050 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2023 | 295 | 0.050 |
Why?
|
| Alanine | 1 | 2023 | 613 | 0.050 |
Why?
|
| Drug Substitution | 1 | 2023 | 292 | 0.040 |
Why?
|
| Divorce | 1 | 2020 | 78 | 0.040 |
Why?
|
| Viral Load | 3 | 2015 | 3385 | 0.040 |
Why?
|
| Baltimore | 1 | 2020 | 233 | 0.040 |
Why?
|
| Chicago | 1 | 2020 | 255 | 0.040 |
Why?
|
| Malaria, Vivax | 1 | 2001 | 168 | 0.040 |
Why?
|
| Comorbidity | 1 | 2013 | 10575 | 0.040 |
Why?
|
| Kainic Acid | 1 | 1998 | 204 | 0.040 |
Why?
|
| Pyridones | 1 | 2023 | 816 | 0.040 |
Why?
|
| New York City | 1 | 2020 | 736 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 3801 | 0.040 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2023 | 669 | 0.040 |
Why?
|
| Middle Aged | 10 | 2023 | 223016 | 0.040 |
Why?
|
| Young Adult | 5 | 2016 | 59857 | 0.040 |
Why?
|
| Coronary Circulation | 1 | 2023 | 1601 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2023 | 2075 | 0.040 |
Why?
|
| Cognition | 1 | 2014 | 7043 | 0.030 |
Why?
|
| Adult | 9 | 2023 | 223088 | 0.030 |
Why?
|
| Cerebral Ventricles | 1 | 1998 | 550 | 0.030 |
Why?
|
| Male | 13 | 2023 | 363815 | 0.030 |
Why?
|
| Yellow Fever | 1 | 2016 | 54 | 0.030 |
Why?
|
| Female | 13 | 2023 | 396141 | 0.030 |
Why?
|
| Asia | 1 | 2016 | 630 | 0.030 |
Why?
|
| Nerve Degeneration | 1 | 1998 | 748 | 0.030 |
Why?
|
| Africa | 1 | 2016 | 725 | 0.030 |
Why?
|
| Rhode Island | 1 | 2014 | 351 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2016 | 81537 | 0.030 |
Why?
|
| HIV-1 | 1 | 2010 | 6945 | 0.030 |
Why?
|
| Caribbean Region | 1 | 2013 | 193 | 0.030 |
Why?
|
| Piperazines | 1 | 2023 | 2546 | 0.030 |
Why?
|
| Consultants | 1 | 2013 | 57 | 0.030 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 1994 | 187 | 0.030 |
Why?
|
| Antidiarrheals | 1 | 2012 | 46 | 0.030 |
Why?
|
| Typhoid-Paratyphoid Vaccines | 1 | 2012 | 40 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2023 | 3094 | 0.020 |
Why?
|
| Brazil | 1 | 2016 | 1248 | 0.020 |
Why?
|
| Hepatitis B Antibodies | 1 | 2013 | 156 | 0.020 |
Why?
|
| Humans | 16 | 2023 | 765926 | 0.020 |
Why?
|
| United States | 3 | 2015 | 72909 | 0.020 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2013 | 293 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2016 | 1527 | 0.020 |
Why?
|
| Friends | 1 | 2012 | 150 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 7473 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 2020 | 2192 | 0.020 |
Why?
|
| HLA-C Antigens | 1 | 2010 | 146 | 0.020 |
Why?
|
| HLA-A Antigens | 1 | 2010 | 223 | 0.020 |
Why?
|
| HIV Long-Term Survivors | 1 | 2010 | 140 | 0.020 |
Why?
|
| HIV Antigens | 1 | 2010 | 328 | 0.020 |
Why?
|
| Aged | 6 | 2023 | 171163 | 0.020 |
Why?
|
| India | 1 | 2016 | 2334 | 0.020 |
Why?
|
| Hepatitis B virus | 1 | 2013 | 532 | 0.020 |
Why?
|
| Hypothalamus | 1 | 1994 | 1005 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2015 | 2586 | 0.020 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2009 | 65 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 1994 | 1674 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 26282 | 0.020 |
Why?
|
| Anti-HIV Agents | 1 | 2023 | 4558 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2012 | 641 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2023 | 6542 | 0.020 |
Why?
|
| Internationality | 1 | 2013 | 1007 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 3430 | 0.020 |
Why?
|
| Prevalence | 2 | 2013 | 15828 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2023 | 22228 | 0.020 |
Why?
|
| Child | 4 | 2016 | 80568 | 0.020 |
Why?
|
| Adolescent | 4 | 2016 | 88811 | 0.020 |
Why?
|
| Social Support | 1 | 2014 | 2190 | 0.010 |
Why?
|
| Amino Acids | 1 | 2010 | 1709 | 0.010 |
Why?
|
| Haplotypes | 1 | 2010 | 2726 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2010 | 3945 | 0.010 |
Why?
|
| Malaria | 1 | 2012 | 1246 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 39228 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2016 | 42510 | 0.010 |
Why?
|
| Massachusetts | 1 | 2014 | 8882 | 0.010 |
Why?
|
| Family | 1 | 2012 | 3208 | 0.010 |
Why?
|
| Mefloquine | 1 | 2001 | 55 | 0.010 |
Why?
|
| Papua New Guinea | 1 | 2001 | 47 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2014 | 8724 | 0.010 |
Why?
|
| Health Behavior | 1 | 2012 | 2649 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2010 | 5377 | 0.010 |
Why?
|
| Developing Countries | 1 | 2013 | 2913 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 12973 | 0.010 |
Why?
|
| Schizophrenia | 1 | 1998 | 6971 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 2001 | 382 | 0.010 |
Why?
|
| Alleles | 1 | 2010 | 6891 | 0.010 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2001 | 389 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 59496 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2010 | 3078 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2010 | 4641 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 20133 | 0.010 |
Why?
|
| Positive-Pressure Respiration | 1 | 2001 | 712 | 0.010 |
Why?
|
| Limbic System | 1 | 1998 | 418 | 0.010 |
Why?
|
| Logistic Models | 1 | 2010 | 13273 | 0.010 |
Why?
|
| Risk Factors | 2 | 2013 | 74850 | 0.010 |
Why?
|
| Aging | 1 | 1994 | 8725 | 0.010 |
Why?
|
| Antimalarials | 1 | 2001 | 910 | 0.010 |
Why?
|
| Disease Progression | 1 | 2010 | 13614 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1994 | 420 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1994 | 386 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1994 | 1546 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2013 | 24275 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 54807 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 12803 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 16039 | 0.010 |
Why?
|
| Rats | 2 | 1998 | 23708 | 0.010 |
Why?
|
| Infant | 1 | 2012 | 36426 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1994 | 2270 | 0.010 |
Why?
|
| Critical Care | 1 | 2001 | 2713 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2010 | 41680 | 0.000 |
Why?
|
| Blotting, Western | 1 | 1994 | 5019 | 0.000 |
Why?
|
| Hippocampus | 1 | 1998 | 3772 | 0.000 |
Why?
|
| Cognition Disorders | 1 | 1998 | 3965 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1994 | 8107 | 0.000 |
Why?
|
| Calcium | 1 | 1994 | 5769 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1994 | 11030 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1994 | 12768 | 0.000 |
Why?
|
| Time Factors | 1 | 1998 | 40097 | 0.000 |
Why?
|
| Neurons | 1 | 1994 | 9527 | 0.000 |
Why?
|
| Animals | 2 | 1998 | 168735 | 0.000 |
Why?
|
| Brain | 1 | 1994 | 27179 | 0.000 |
Why?
|
Concepts
(163)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(33)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_